Literature DB >> 3533991

Torulopsis candida, a new opportunistic pathogen.

G St-Germain, M Laverdière.   

Abstract

We described the first documented case of intravenous-catheter-associated fungemia caused by Torulopsis candida (Candida famata). The microorganism was isolated from two blood cultures and one intravenous catheter tip in a bone marrow transplant patient. Both the intravascular cannula and the immunological status of the patient are believed to have played major roles in predisposing the patient to such an infection. Uneventful recovery occurred after the removal of the catheter and amphotericin B therapy.

Entities:  

Mesh：

Year:  1986        PMID： 3533991      PMCID： PMC269054          DOI： 10.1128/jcm.24.5.884-885.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Venous catheter-associated candidemia.

Authors:  H D Rose
Journal:  Am J Med Sci       Date:  1978 May-Jun       Impact factor: 2.378

2.  The ecology of Torulopsis in man.

Authors:  J Barthe; M F Barthe
Journal:  Sabouraudia       Date:  1973-07

3.  A semiquantitative culture method for identifying intravenous-catheter-related infection.

Authors:  D G Maki; C E Weise; H W Sarafin
Journal:  N Engl J Med       Date:  1977-06-09       Impact factor: 91.245

4.  Pathogenicity of some ordinarily harmless yeasts for cortisone-treated mice.

Authors:  Z U Khan; V C Misra; H S Randhawa; V N Damodaran
Journal:  Sabouraudia       Date:  1980-12

5.  Intravenous catheter-associated fungemia due to Candida rugosa.

Authors:  J F Reinhardt; P J Ruane; L J Walker; W L George
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

6.  Osteomyelitis of the hand due to Torulopsis holmii.

Authors:  C B Murdock; J F Fisher; D Loebl; W H Chew
Journal:  South Med J       Date:  1983-11       Impact factor: 0.954

7.  [Therapy of fungal septicemia and bounds (author's transl)].

Authors:  S Albaret; P Hoquet; J F Cavellat; A Delhumeau; M Cavellat
Journal:  Anesth Analg (Paris)       Date:  1979 Jan-Feb
  7 in total
  12 in total

1.  Candida famata fungemia in a surgical patient successfully treated with fluconazole.

Authors:  G Carrega; G Riccio; L Santoriello; M Pasqualini; R Pellicci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

Review 2.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

3.  Evaluation of four commercial systems for identification of medically important yeasts.

Authors:  I Schuffenecker; A Freydière; H de Montclos; Y Gille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

Review 4.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Isolation of Candida famata from a patient with acute zonal occult outer retinopathy.

Authors:  Luis Carrasco; Marta Ramos; Rebeca Galisteo; Diana Pisa; Manuel Fresno; María Eugenia González
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

6.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

7.  Evaluation of the Baxter-MicroScan 4-hour enzyme-based yeast identification system.

Authors:  G A Land; I F Salkin; M el-Zaatari; M R McGinnis; G Hashem
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

8.  Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii).

Authors:  Marie Desnos-Ollivier; Marie Ragon; Vincent Robert; Dorothée Raoux; Jean-Charles Gantier; Françoise Dromer
Journal:  J Clin Microbiol       Date:  2008-08-13       Impact factor: 5.948

9.  In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis; R N Jones
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs.

Authors:  Mariana Castanheira; Leah N Woosley; Daniel J Diekema; Ronald N Jones; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.